Latest Entitlement Offer News

Neurizon Therapeutics has cleared a major regulatory hurdle with the FDA lifting the clinical hold on its lead drug NUZ-001 and secured a comprehensive $33 million funding package to advance its pivotal ALS trial.

Premier1 Lithium has significantly expanded its gold-in-soil anomaly at the Rochefort Prospect and secured $2.17 million in fresh capital to accelerate exploration at its Western Australian projects.

Coda Minerals secured $12.33 million in capital to advance a major drilling campaign and pre-feasibility study at its Elizabeth Creek copper-silver project, maintaining a strong cash position as commodity prices surge.

ENRG Elements Limited has secured $2 million through a capital raise, renewed key uranium exploration permits in Niger, and is strategically pivoting towards gold opportunities in Central Asia, alongside a corporate rebranding to Barys Resources Limited.

NuEnergy Gas Limited has completed drilling four wells at its Tanjung Enim project, gearing up for initial gas sales in the first half of FY26. The company also inked key agreements to finance and expand its coal bed methane operations in Indonesia.

Jatcorp Limited reported a striking 165% revenue increase in Q2 FY26, driven by strong demand in Australia, Hong Kong, and China. The company also secured $4.2 million through an entitlement offer to support its growth ambitions across Southeast Asia.

InhaleRx Limited has progressed its clinical trials for three drug candidates targeting cancer pain, panic disorder, and treatment-resistant depression, while securing additional funding and preparing for a company rebrand.

Carnavale Resources has marked key progress at its Kookynie Gold Project, signing a pivotal Heritage and Mining Agreement and launching a Bankable Feasibility Study aimed at production by mid-2026.

MEC Resources has bolstered its stake in Advent Energy with a $1.55 million loan while navigating a pivotal Federal Court hearing on the PEP 11 Joint Venture. Meanwhile, progress on Clean Hydrogen Technology signals potential growth avenues.

Biotron Limited has completed the acquisition of Sedarex Limited alongside a $2.5 million capital raising, while its lead Hepatitis B drug candidate BIT-HBV001 shows promising preclinical results outperforming current treatments.

Eagle Mountain Mining has made significant strides this quarter, including a $1.66 million capital raise and a potential joint venture with Japan’s Nittetsu Mining to develop its Oracle Ridge copper project.

Riedel Resources has completed a key drilling program at its Kingman Gold Project in Arizona and secured $1.78 million through an entitlement offer, while appointing Adrien Wing to its board.